CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study

Original Research2016 Jul 19;68(3):313-321.

JOURNAL:J Am Coll Cardiol. Article Link

Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines

Rodriguez F, Mahaffey KW. Keywords: acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment

FULL TEXT PDF